Codes / ICD10CM / E10.37X3

E10.37X3 Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral

Summary

Type 1 diabetes mellitus is a chronic autoimmune condition characterized by insufficient insulin production. When diabetic macular edema is present and resolved following treatment in both eyes, it indicates prior fluid accumulation in the macula due to prolonged hyperglycemia, which has been addressed with intervention. This condition requires ongoing monitoring to prevent recurrence and maintain visual health in both eyes.

Causes

Type 1 diabetes arises from an autoimmune response that destroys insulin-producing beta cells in the pancreas. Diabetic macular edema develops as a result of sustained high blood glucose levels, which damage retinal blood vessels and lead to fluid leakage into the macula. The exact mechanisms involve oxidative stress, inflammation, and vascular changes specific to ocular structures. Resolution occurs when treatment reduces fluid accumulation and restores macular integrity in both eyes.

Risk Factors

  • Poor glycemic control
  • Duration of diabetes (longer exposure increases risk)
  • Hypertension
  • Dyslipidemia
  • Smoking
  • Genetic predisposition to diabetic eye disease

Symptoms

  • Blurred or distorted vision in both eyes
  • Floaters or spots in the visual field of both eyes
  • Difficulty seeing in low light
  • Fluctuating vision levels
  • Sudden vision loss (in severe cases)

Diagnosis

Diagnosis involves a comprehensive eye examination, including visual acuity testing, dilated retinal examination, and imaging studies such as optical coherence tomography (OCT) to assess macular thickness and fluid presence. Fluorescein angiography may be used to evaluate retinal blood vessel leakage. Resolution is confirmed when imaging shows reduced macular edema and improved visual function following treatment.

Treatment Options

Treatment typically includes anti-VEGF injections, corticosteroids, or laser therapy to reduce macular fluid. Glycemic control through insulin therapy and lifestyle modifications is essential to prevent recurrence. Regular follow-up with an ophthalmologist is required to monitor for relapse.

Prognosis and Follow-Up

With proper treatment and glycemic management, prognosis is generally favorable, though recurrence is possible. Long-term follow-up with both endocrinologists and ophthalmologists is necessary to maintain visual health and prevent complications.

Complications

  • Recurrence of macular edema
  • Progressive vision loss if untreated
  • Increased risk of other diabetic eye conditions (e.g., retinopathy)

Lifestyle & Prevention

  • Maintain strict glycemic control through insulin therapy and diet
  • Regular exercise and weight management
  • Avoid smoking and limit alcohol intake
  • Routine eye examinations to detect early changes

When to Seek Professional Help

Seek immediate care if you experience sudden vision changes, increased floaters, or persistent blurred vision in either eye, as these may indicate recurrence or other complications.

Tips for Medical Coders

Document the bilateral nature of the resolved macular edema and confirm treatment intervention. Ensure clinical notes specify resolution status and affected eyes to support accurate coding.

Book a walkthrough

E10.37X3 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.